Publicaciones I.E.N. Diabetes Mellitus VI
| d.67 |
JL Perez, DA de Luis, JA Riancho, E rey, D Guede, M Gonzalez, M Ruiz, M Domingo, D Primo. Estudio estructural mediante micro CT en fémur de ratas Goto Kakizaki modelo experimental de diabetes tipo 2 sin sobrepeso. Rev Osteopor Metab Miner 2011;3:95-10 |
· |
| d.68 |
Aller R, Perez Castrillon JL, de Luis DA, Conde R, Izaola O, González Sagrado M, Concepción Velasco M, Alvarez T, Pacheco D. Relation of osteocalcin with insulin resistance and histopathological changes of non alcoholic fatty liver disease. Ann Hepatol. 2011 Jan 3;10(1):50-5. FI 1,67 |
· |
| d.69 |
DA de Luis, M Gonzalez, R Aller, O Izaola, R conde. Relation of G1359A polymorphism of the canabinnoid receptor (CB1) gene with metabolic syndrome by ATPIII classification. Diabetes Metab Res Rev 2011; 27:506-511. FI3,094 |
· |
| d.70 |
DA de Luis, M Goznalez, R Aller, O Izaola, R Conde, MJ Castro. Lys656Asn polymorphism of leptin receptor gene and metabolic syndrome in obese patients. Eur Rev Med Pharmacol Sci 2011;15:463-468. FI 0,773 |
· |
| d.71 |
DA de Luis, R Aller, O Izaola, R Conde, M Gonzalez. The ratio of adiponectin to HOMA as an Index of Metabolic syndrome in obese women. Ann Nutr Met 2011;58:301-306 FI 1,97 |
· |
| d.72 |
DA de Luis, M Gonzalez, R Conde, R Aller, O izaola, D Primo. Lack of association of serum resistin levels with metabolic syndrome criteria in obese female patients. Clinical Biochemistry 2011:44:1280-1283 |
· |
| d.73 |
Aller R, De Luis DA, Izaola O, Conde R, Gonzalez Sagrado M, Primo D, De La Fuente B, Gonzalez J Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: a double blind randomized clinical trial. Eur Rev Med Pharmacol Sci. 2011 Sep;15(9):1090-5. FI 0,773 |
· |
| d.74 |
de Luis DA, Aller R, Izaola O, Ovalle HF. The serum profile of adipokines in naïve patients with diabetes mellitus type 2 and obesity. J Clin Lab Anal. 2011 Nov;25(6):409-13. FI 1,031 |
· |
| d.75 | R Aller, DA de Luis, D Pacheco, M Velasco, O Izaola, B de la fuente. Influence of G1359, polymorphism of the cannabinoid receptor gene on insulin resistance and adipokines in patients with NAFLD. Nutr Hosp 2012; 1648-1654 FI 1,120 |
· |
| d.76 | RICARDO GÓMEZ HUELGAS, JAVIER DÍEZ-ESPINO, FRANCESC FORMIGA, JAVIER LAFITA TEJEDOR, LEOCADIO RODRÍGUEZ MAÑAS, ENRIQUE GONZÁLEZ-SARMIENTO, EDELMIRO MENÉNDEZ, JAVIER SANGRÓS, en nombre del Grupo de Trabajo para el Documento de Consenso sobre el tratamiento de la diabetes tipo 2 en el anciano “Tratamiento de la diabetes tipo 2 en el paciente anciano. Treatment of type 2 diabetes in the elderly” Med Clin (Bar). 2012. Nov 28 |
· |
| d.77 | R Aller, DA de Luis, O Izaola, M gonzalez, R Conde, D Pacheco, M C Velasco, HF Ovalle. Lys 656Asn polymorphism of leptin receptor, leptin levels and insulin resistance in patients with non alcoholic fatty liver disease. Eur Rev for med and Pharmacol Sci 2012:16:335-341. FI 0,773 |
· |
| d.78 | DA de luis, R Aller, O Izaola, M Gonzalez, R Conde, MJ castro. Interaction of 55CT polymorphism of UCP3 gene with Trp64Arg polymorphism of beta3adrenoreceptor gene on insulin resistance in obese patients. Eur Rev for med and Pharmacol Sci 2012:16:610-616. FI 0,773 |
· |
| d.79 | DA de Luis, R Aller, O Izaola, R Conde, M Gonzalez, D Primo, MJ Castro. relationship among metabolic syndrome,C358A polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) and insulin resistance. Journal of Diabetes and Clinical Complications 2012;26:328-332.FI 2.03 |
· |
| d.80 | DA de Luis, M Domingo, A Romero, M Gonzalez, D Pacheco, D Primo, R Conde. Effects of duodenal-jejunal exclusion on beta cell function and homronal regulation in Goto Kakizaki rats. The American Journal of Surgery 2012;204:242-247 FI 2.337 |
· |
| d.81 | DA de Luis, R Aller, O Izaola, M Gonzalez R Conde, D Primo, B de la Fuente, H Ovalle, M Ruiz. Relationship of -55C/T polymorphism of UCP3 gene with metabolic syndrome by ATP III classification. J of CLinical Lab Analysis 2012;26:272-278. FI 1,031 |
· |
| d.82 | DA de Luis, R Aller, R conde, D Primo, O Izaola, MJ Castro, M Gonzalez. Basal GLP-1 levels and metabolic syndrome in obese patients. J Invest Medicine 2012;60;874-878. FI 1,96 |
· |
| d.83 | DA de Luis, R Aller, O Izaola, M Gonzalez, R Conde. Association of -55CT polymorphism of UCP3 gene with fat distribution, cardiovascular risk factors and adipocytokines in patients with type 2 diabetes mellitus. J Endocrinol Invest 2012;35;625-628 FI 1,566 |
· |
| d.84 | Marga Giménez, Juan José López Gómez, Conxa Castell, Ignacio Conget.Hypoglycaemia and cardiovascular disease in Type 1 Diabetes. Results from the Catalan National Health Service registry on insulin pump therapy. Diabetes Res Clin Pract. 2012 May;96(2):e23-5 |
· |
| d.85 | RA Aller , DA de Luis, D Pacheco, M velasco. Insulin resistance predicts steatosis and fibrosis in morbidly obese patients undergoin bariatric surgery. J Invest Med 2012; 60:1005-1008 FI 1,96 |
· |
| d.86 | DEVRIES JH, BAIN SC, RODBARD HW, SEUFERT J, D'ALESSIO D, THOMSEN AB, ZYCHMA M, ROSENSTOCK J; LIRAGLUTIDE-DETEMIR STUDY GROUP. “Sequential intensification of metformin treatment in type 2 diabetes with liraglutide followed by randomized addition of basal insulin prompted by A1C targets”. Diabetes Care. 2012 Jul;35(7):1446-54 |
· |